Total Funding
69
61
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
93148
RenalSense is building a Realtime Diagnostic Platform for Acute Kidney Injury (AKI) in Critical Care: Detection, Prevention, Management
- Avi Kleiman: CEO
About the Company
While prevention of kidney injury is highly dependent on early detection of potential risk, the industry has no solutions to address this need. Conventional products and protocols can only report kidney damage after it exists - not prevent it. The growing unmet need for early detection and prevention of risk and for the tools to improve the
management of AKI patients in critical care have established the necessity of realtime renal diagnostics solutions.
RenalSense's unique products will set new clinical gold standards, improve outcomes and reduce the cost of care.
